The global Pharmaceutical Gelatin Market, valued at USD 1.15 billion in 2022, is anticipated to witness significant growth, reaching USD 1.76 billion by 2030. This growth reflects a Compound Annual Growth Rate (CAGR) of 5.4% over the forecast period of 2023-2030.Pharmaceutical gelatin serves as a critical ingredient in the formulation of various pharmaceutical products, including capsules, tablets, and coatings. It offers unique properties such as gelling ability, stability, and biocompatibility, making it indispensable in the pharmaceutical industry.

Get Sample PDF @ 


Major key players are Capsugel, Gelita AGv, Catelent Inc., Rousselot, Sterling Gelatin, Norland Products Inc, Weishardt, Tessenderlo Group, Roxlor llc, Nitta Gelatin Inc, and other players.

Key factors driving the growth of the pharmaceutical gelatin market include:

  1. Increasing Pharmaceutical Production: The growing demand for pharmaceutical products worldwide, driven by population growth, aging demographics, and the prevalence of chronic diseases, fuels the demand for pharmaceutical gelatin. Gelatin serves as a versatile excipient in drug formulations, contributing to the growth of the pharmaceutical industry.

  2. Rising Preference for Gelatin Capsules: Gelatin capsules remain a popular choice for oral drug delivery due to their ease of swallowing, biodegradability, and compatibility with a wide range of active pharmaceutical ingredients (APIs). The demand for gelatin capsules in both prescription and over-the-counter (OTC) medications drives the consumption of pharmaceutical gelatin.

  3. Technological Advancements in Gelatin Production: Ongoing advancements in gelatin manufacturing processes, including hydrolysis methods, purification techniques, and quality control measures, improve the quality, consistency, and safety of pharmaceutical gelatin. Enhanced gelatin quality and purity meet stringent regulatory requirements and support the development of innovative pharmaceutical formulations.

  4. Growing Emphasis on Clean Label and Natural Ingredients: Consumer preference for clean label and natural products drives the demand for pharmaceutical gelatin sourced from natural and sustainable raw materials. Gelatin derived from bovine, porcine, or fish collagen meets clean label requirements and aligns with consumer preferences for natural ingredients in pharmaceuticals.


By Application

  • Hard Capsules

  • Soft Capsules

  • Tablets

  • Absorbable Hemostats

By Source

  • Porcine

  • Bovine Skin

  • Bovine Bone

  • Marine

  • Poultry

By Function

  • Stabilizing agents

  • Thickening agents

  • Gelling agents & Other Functions

By Type

  • Type A

  • Type B

The forecasted growth of the pharmaceutical gelatin market presents significant opportunities for manufacturers to expand their product portfolios and cater to the evolving needs of the pharmaceutical industry. Key players are focusing on product innovation, quality assurance, and sustainability initiatives to maintain their competitive edge in the market.

Geographically, North America currently dominates the pharmaceutical gelatin market, driven by the presence of major pharmaceutical manufacturers, robust healthcare infrastructure, and high consumer demand for gelatin-based pharmaceutical products. However, other regions, including Europe and Asia-Pacific, are expected to witness substantial growth during the forecast period, fueled by increasing pharmaceutical production and rising healthcare expenditure.

Check Discount On Pharmaceutical Gelatin Market @ 

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)